Left Ventricular Assist Device (LVAD) as a Bridge to Recovery for Tachycardia-Mediated Cardiomyopathy.
A case is described of cardiogenic shock that occurred following use of sotalol in a patient with severe left ventricular dysfunction. The patient required left ventricular assist device (LVAD) placement with subsequent myocardial recovery to a degree that allowed eventual device removal following 140 days of support.
Department of Advanced Heart Failure and Transplantation, The Alfred Hospital and Monash University, Melbourne, Australia.
Michael B
MB
Stokes
Department of Cardiothoracic Surgery, The Alfred Hospital and Monash University, Melbourne, Australia.
Pankaj
P
Saxena
Department of Advanced Heart Failure and Transplantation, The Alfred Hospital and Monash University, Melbourne, Australia.
Justin A
JA
Mariani
Department of Advanced Heart Failure and Transplantation, The Alfred Hospital and Monash University, Melbourne, Australia.
David M
DM
Kaye
Department of Advanced Heart Failure and Transplantation, The Alfred Hospital and Monash University, Melbourne, Australia.
Peter
P
Bergin
Department of Cardiothoracic Surgery, The Alfred Hospital and Monash University, Melbourne, Australia.
David C
DC
McGiffin
D000889:Anti-Arrhythmia Agents / Q000009:adverse effects; D009202:Cardiomyopathies / Q000209:etiology / Q000628:therapy*; D006352:Heart Ventricles; D006353:Heart-Assist Devices; D006801:Humans; D008297:Male; D008875:Middle Aged; D012720:Severity of Illness Index; D012770:Shock, Cardiogenic / Q000209:etiology / Q000628:therapy*; D013015:Sotalol / Q000009:adverse effects; D013610:Tachycardia / Q000209:etiology / Q000628:therapy*; D013997:Time Factors; D016896:Treatment Outcome; D018487:Ventricular Dysfunction, Left / Q000150:complications
D000889:Anti-Arrhythmia Agents; D013015:Sotalol